Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CKLIFE SCIENCES Presents Research Findings on Inhibiting Tumour Growth at SITC Annual Meeting
Recommend 18 Positive 17 Negative 6 |
||||
|
||||
|
CKLIFE SCIENCES (00775.HK) presented preclinical research data from its therapeutic cancer vaccine development series at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting, held successfully in National Harbor, State of Maryland, the US. The presentation highlighted significant progress in the development of cancer vaccines targeting the trophoblast cell-surface antigen 2 (TROP2), preferentially expressed antigen in melanoma (PRAME) and programmed death-ligand 1 (PD-L1). CKLIFE SCIENCES also demonstrated the vaccines' potential to inhibit tumour growth. AAStocks Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
